missing translation for 'onlineSavingsMsg'
Få mere at vide
  1. Home
  2. Products
  3. Kemikalier
  4. Organiske forbindelser
  5. Organoheterocykliske forbindelser
  6. Azoler
  7. Imidazoler
  8. CCT129202, MedChemExpress

CCT129202, MedChemExpress

Artikelnummer. 16485726
Encompass_Preferred
Skift visning
Klik for at se tilgængelige muligheder
Mængde:
5 mg
10 mg
50 mg
100 mg
4 product options available for selection
Product selection table with 4 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Mængde
16485726 100 mg
16481197 50 mg
16414958 10 mg
16407697 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 4 options available.
4 options
Denne vare kan ikke returneres. Se returpolicy
Artikelnummer. 16485726 Leverandør Medchem Express Leverandørnr. HY12049

Venligst for at købe denne vare. Brug for en webkonto? Register dig hos os i dag!

Denne vare kan ikke returneres. Se returpolicy

Beskrivelse

MedChemExpress CCT129202 is an aurora kinase inhibitor with IC50s of 42, 198, and 227 nM for aurora A, B and C, respectively.

CCT129202 is an aurora kinase inhibitor with IC50s of 42, 198, and 227 nM for aurora A, B and C, respectively.

Specifications

Kemisk navn eller materiale CCT129202
CAS 942947-93-5
Farve Yellow
Renhedsgrad noter Research
Molekylær formel C23H25ClN8OS
Mængde 100 mg
Opløselighedsinformation DMSO : 1 mg/mL (2.01 mM; Need ultrasonic)
SMIL CN(C1=CC=C(C2=NC3=C(C(Cl)=CN=C3N2)N4CCN(CC4)CC(NC5=NC=CS5)=O)C=C1)C
Molekylvægt (g/mol) 497.02
Formel vægt 497.02
Procent renhed 98.24%
Grad Research
Fysisk form Solid
Til brug med (applikation) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.